Status:
COMPLETED
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
Lead Sponsor:
University of Pennsylvania
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
14-21 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual...
Eligibility Criteria
Inclusion
- Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
223 Patients enrolled
Trial Details
Trial ID
NCT00078130
Start Date
July 1 2003
End Date
January 1 2006
Last Update
January 12 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Mercy Hospital
Portland, Maine, United States, 04092
2
Mountain Manor
Baltimore, Maryland, United States, 21229
3
ASAP
Albuquerque, New Mexico, United States, 87106
4
Duke Addictions Program
Durham, North Carolina, United States, 27710